- Home
- Publications
- Publication Search
- Publication Details
Title
HDAC inhibitors in HIV
Authors
Keywords
-
Journal
IMMUNOLOGY AND CELL BIOLOGY
Volume 90, Issue 1, Pages 47-54
Publisher
Wiley
Online
2011-11-15
DOI
10.1038/icb.2011.95
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epigenetic regulation in myelodysplastic syndromes: implications for therapy
- (2016) Ernesto Vigna et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- An In Vitro System to Model the Establishment and Reactivation of HIV-1 Latency
- (2014) A. Marini et al. JOURNAL OF IMMUNOLOGY
- HIV-1 Reactivation Induced by Apicidin Involves Histone Modification in Latently Infected Cells
- (2012) Shiguan Lin et al. CURRENT HIV RESEARCH
- Chemosensitization of glioblastoma cells by the histone deacetylase inhibitor MS275
- (2011) Annette Bangert et al. ANTI-CANCER DRUGS
- Biomarkers of immune dysfunction following combination antiretroviral therapy for HIV infection
- (2011) Gregor F Lichtfuss et al. Biomarkers in Medicine
- The histone deacetylase inhibitor sodium butyrate in combination with brain-derived neurotrophic factor reduces the viability of DAOY human medulloblastoma cells
- (2011) Carolina Nör et al. CHILDS NERVOUS SYSTEM
- Novel histone deacetylase inhibitor NCH-51 activates latent HIV-1 gene expression
- (2011) Ann Florence B. Victoriano et al. FEBS LETTERS
- Inhibitors of Histone Deacetylases
- (2011) Kelly Huber et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- High-throughput Screening Uncovers a Compound That Activates Latent HIV-1 and Acts Cooperatively with a Histone Deacetylase (HDAC) Inhibitor
- (2011) Sofiya Micheva-Viteva et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Disulfiram Reactivates Latent HIV-1 in a Bcl-2-Transduced Primary CD4+ T Cell Model without Inducing Global T Cell Activation
- (2011) S. Xing et al. JOURNAL OF VIROLOGY
- Unknown
- (2011) Shay Matalon et al. MOLECULAR MEDICINE
- Activation of Latent HIV Using Drug-Loaded Nanoparticles
- (2011) Michael Kovochich et al. PLoS One
- HIV reservoirs and latency models
- (2011) Matthew J. Pace et al. VIROLOGY
- Novel histone deacetylase inhibitors CG05 and CG06 effectively reactivate latently infected HIV-1
- (2010) Byeong-Sun Choi et al. AIDS
- Bryostatin-1 Synergizes with Histone Deacetylase Inhibitors to Reactivate HIV-1 from Latency
- (2010) Moises Perez et al. CURRENT HIV RESEARCH
- Histone deacetylase inhibitors: potential targets responsible for their anti-cancer effect
- (2010) Michael Dickinson et al. INVESTIGATIONAL NEW DRUGS
- The Histone Deacetylase Inhibitor ITF2357 Decreases Surface CXCR4 and CCR5 Expression on CD4+ T-Cells and Monocytes and is Superior to Valproic Acid for Latent HIV-1 Expression in Vitro
- (2010) Shay Matalon et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Combinatorial Latency Reactivation for HIV-1 Subtypes and Variants
- (2010) J. C. Burnett et al. JOURNAL OF VIROLOGY
- Vorinostat, a histone deacetylase inhibitor, combined with pelvic palliative radiotherapy for gastrointestinal carcinoma: the Pelvic Radiation and Vorinostat (PRAVO) phase 1 study
- (2010) Anne Hansen Ree et al. LANCET ONCOLOGY
- Valproic acid stimulates clusterin expression in human astrocytes: Implications for Alzheimer's disease
- (2010) Tapio Nuutinen et al. NEUROSCIENCE LETTERS
- Antiretroviral Intensification and Valproic Acid Lack Sustained Effect on Residual HIV-1 Viremia or Resting CD4+ Cell Infection
- (2010) Nancie M. Archin et al. PLoS One
- Establishment of HIV-1 latency in resting CD4+ T cells depends on chemokine-induced changes in the actin cytoskeleton
- (2010) P. U. Cameron et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cell line-dependent variability in HIV activation employing DNMT inhibitors
- (2010) Guerau Fernandez et al. Virology Journal
- Prolonged valproic acid treatment does not reduce the size of latent HIV reservoir
- (2009) Nathalie Sagot-Lerolle et al. AIDS
- HIV integration site distributions in resting and activated CD4+ T cells infected in culture
- (2009) Troy Brady et al. AIDS
- Expression of latent human immunodeficiency type 1 is induced by novel and selective histone deacetylase inhibitors
- (2009) Nancie M Archin et al. AIDS
- The novel histone deacetylase inhibitors metacept-1 and metacept-3 potently increase HIV-1 transcription in latently infected cells
- (2009) Miranda Shehu-Xhilaga et al. AIDS
- Expression of Latent HIV Induced by the Potent HDAC Inhibitor Suberoylanilide Hydroxamic Acid
- (2009) Nancie M. Archin et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Extensive astrocyte infection is prominent in human immunodeficiency virus-associated dementia
- (2009) Melissa J. Churchill et al. ANNALS OF NEUROLOGY
- Chromatin dynamics associated with HIV-1 Tat-activated transcription
- (2009) Rebecca Easley et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Regulation of Treg functionality by acetylation-mediated Foxp3 protein stabilization
- (2009) J. van Loosdregt et al. BLOOD
- An HDAC inhibitor enhances the antitumor activity of a CMV promoter-driven DNA vaccine
- (2009) M-D Lai et al. CANCER GENE THERAPY
- Vorinostat Inhibits Brain Metastatic Colonization in a Model of Triple-Negative Breast Cancer and Induces DNA Double-Strand Breaks
- (2009) D. Palmieri et al. CLINICAL CANCER RESEARCH
- Clinical Studies of Histone Deacetylase Inhibitors
- (2009) H. M. Prince et al. CLINICAL CANCER RESEARCH
- Reactivation of DNA viruses in association with histone deacetylase inhibitor therapy: a case series report
- (2009) D. Ritchie et al. HAEMATOLOGICA
- Sodium valproate in combination with ganciclovir induces lysis of EBV-infected lymphoma cells without impairing EBV-specific T-cell immunity
- (2009) K. JONES et al. International Journal of Laboratory Hematology
- Suberoylanilide Hydroxamic Acid Reactivates HIV from Latently Infected Cells
- (2009) Xavier Contreras et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Determinants of the Establishment of Human Immunodeficiency Virus Type 1 Latency
- (2009) A. Duverger et al. JOURNAL OF VIROLOGY
- A Limited Group of Class I Histone Deacetylases Acts To Repress Human Immunodeficiency Virus Type 1 Expression
- (2009) K. S. Keedy et al. JOURNAL OF VIROLOGY
- Understanding HIV-1 latency provides clues for the eradication of long-term reservoirs
- (2009) Mayte Coiras et al. NATURE REVIEWS MICROBIOLOGY
- Synergistic Activation of HIV-1 Expression by Deacetylase Inhibitors and Prostratin: Implications for Treatment of Latent Infection
- (2009) Sophie Reuse et al. PLoS One
- Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies
- (2009) Laurence Colin et al. Retrovirology
- "Shock and kill" effects of class I-selective histone deacetylase inhibitors in combination with the glutathione synthesis inhibitor buthionine sulfoximine in cell line models for HIV-1 quiescence
- (2009) Andrea Savarino et al. Retrovirology
- Valproic acid without intensified antiviral therapy has limited impact on persistent HIV infection of resting CD4+ T cells
- (2008) Nancy M Archin et al. AIDS
- Vorinostat inhibits STAT6-mediated TH2 cytokine and TARC production and induces cell death in Hodgkin lymphoma cell lines
- (2008) D. Buglio et al. BLOOD
- Induction of HIV-1 latency and reactivation in primary memory CD4+ T cells
- (2008) A. Bosque et al. BLOOD
- Histone Deacetylase Inhibitor Panobinostat Induces Clinical Responses with Associated Alterations in Gene Expression Profiles in Cutaneous T-Cell Lymphoma
- (2008) L. Ellis et al. CLINICAL CANCER RESEARCH
- Practical Synthesis of Prostratin, DPP, and Their Analogs, Adjuvant Leads Against Latent HIV
- (2008) P. A. Wender et al. SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now